Acid-Sensing Ion Channels Activated by Evoked Released Protons Modulate Synaptic Transmission at the Mouse Calyx of Held Synapse

Acid-sensing ion channels (ASICs) regulate synaptic activities and play important roles in neurodegenerative diseases. We found that these channels can be activated in neurons of the medial nucleus of the trapezoid body (MNTB) of the auditory system in the CNS. A drop in extracellular pH induces transient inward ASIC currents (IASICs) in postsynaptic MNTB neurons from wild-type mice. The inhibition of IASICs by psalmotoxin-1 (PcTx1) and the absence of these currents in knock-out mice for ASIC-1a subunit (ASIC1a−/−) suggest that homomeric ASIC-1as are mediating these currents in MNTB neurons. Furthermore, we detect ASIC1a-dependent currents during synaptic transmission, suggesting an acidification of the synaptic cleft due to the corelease of neurotransmitter and H+ from synaptic vesicles. These currents are capable of eliciting action potentials in the absence of glutamatergic currents. A significant characteristic of these homomeric ASIC-1as is their permeability to Ca2+. Activation of ASIC-1a in MNTB neurons by exogenous H+ induces an increase in intracellular Ca2+. Furthermore, the activation of postsynaptic ASIC-1as during high-frequency stimulation (HFS) of the presynaptic nerve terminal leads to a PcTx1-sensitive increase in intracellular Ca2+ in MNTB neurons, which is independent of glutamate receptors and is absent in neurons from ASIC1a−/− mice. During HFS, the lack of functional ASICs in synaptic transmission results in an enhanced short-term depression of glutamatergic EPSCs. These results strongly support the hypothesis of protons as neurotransmitters and demonstrate that presynaptic released protons modulate synaptic transmission by activating ASIC-1as at the calyx of Held–MNTB synapse.Fil: González Inchauspe, Carlota María Fabiola. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Fisiología, Biología Molecular y Neurociencias. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Fisiología, Biología Molecular y Neurociencias; ArgentinaFil: Urbano Suarez, Francisco Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Fisiología, Biología Molecular y Neurociencias. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Fisiología, Biología Molecular y Neurociencias; ArgentinaFil: Di Guilmi, Mariano Nicolás. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Fisiología, Biología Molecular y Neurociencias. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Fisiología, Biología Molecular y Neurociencias; ArgentinaFil: Uchitel, Osvaldo Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Fisiología, Biología Molecular y Neurociencias. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Fisiología, Biología Molecular y Neurociencias; Argentin

Glycine Receptors Support Excitatory Neurotransmitter Release in Developing Mouse Visual Cortex.

Glycine receptors (GlyRs) are found in most areas of the brain, and their dysfunction can cause severe neurological disorders. While traditionally thought of as inhibitory receptors, presynaptic-acting GlyRs (preGlyRs) can also facilitate glutamate release under certain circumstances, although the underlying molecular mechanisms are unknown. In the current study, we sought to better understand the role of GlyRs in the facilitation of excitatory neurotransmitter release in mouse visual cortex. Using whole-cell recordings, we found that preGlyRs facilitate glutamate release in developing, but not adult, visual cortex. The glycinergic enhancement of neurotransmitter release in early development depends on the high intracellular to extracellular Cl(-) gradient maintained by the Na(+)-K(+)-2Cl(-) cotransporter and requires Ca(2+) entry through voltage-gated Ca(2+) channels. The glycine transporter 1, localized to glial cells, regulates extracellular glycine concentration and the activation of these preGlyRs. Our findings demonstrate a developmentally regulated mechanism for controlling excitatory neurotransmitter release in the neocortex

Calcium-independent inhibitory G-protein signaling induces persistent presynaptic muting of hippocampal synapses

Adaptive forms of synaptic plasticity that reduce excitatory synaptic transmission in response to prolonged increases in neuronal activity may prevent runaway positive feedback in neuronal circuits. In hippocampal neurons, for example, glutamatergic presynaptic terminals are selectively silenced, creating mute synapses, after periods of increased neuronal activity or sustained depolarization. Previous work suggests that cAMP-dependent and proteasome-dependent mechanisms participate in silencing induction by depolarization, but upstream activators are unknown. We, therefore, tested the role of calcium and G-protein signaling in silencing induction in cultured hippocampal neurons. We found that silencing induction by depolarization was not dependent on rises in intracellular calcium, from either extracellular or intracellular sources. Silencing was, however, pertussis toxin sensitive, which suggests that inhibitory G-proteins are recruited. Surprisingly, blocking four common inhibitory G-protein-coupled receptors (GPCRs) (adenosine A(1) receptors, GABA(B) receptors, metabotropic glutamate receptors, and CB(1) cannabinoid receptors) and one ionotropic receptor with metabotropic properties (kainate receptors) failed to prevent depolarization-induced silencing. Activating a subset of these GPCRs (A(1) and GABA(B)) with agonist application induced silencing, however, which supports the hypothesis that G-protein activation is a critical step in silencing. Overall, our results suggest that depolarization activates silencing through an atypical GPCR or through receptor-independent G-protein activation. GPCR agonist-induced silencing exhibited dependence on the ubiquitin-proteasome system, as was shown previously for depolarization-induced silencing, implicating the degradation of vital synaptic proteins in silencing by GPCR activation. These data suggest that presynaptic muting in hippocampal neurons uses a G-protein-dependent but calcium-independent mechanism to depress presynaptic vesicle release

The role of psychotherapy in chronic pain management

IntroductionAs chronic pain occurs in about 20% of the population, pain management is becoming a more and more crucial branch of medicine and its importance in many fields of medicine increases and is more appreciated. Pain is not only a physical experience, but also has a sensory and emotional component so the modern approach to pain treatment should not be limited to pharmacological treatment alone, but also should provide appropriate multifaceted psychological support to the patient and his relatives.State of knowledgePathophysiological mechanisms of developing pain can not be unmentioned while analyzing the pain management and effectiveness of psychotherapy , because physiological and psychological aspects of the human body's functioning are inextricably connected. Knowledge of pain assessment methods is always crucial to lead the psychotherapy in a proper and effective way. The mainstay of pain management is pharmacotherapy, using drug groups such as opioids and non-opioid analgesics , but the role of psychotherapy is also very important and there is much research, which proves it. SummaryMultidisciplinary treatment of patients with chronic pain is widely recommended, as well as paying attention not only to the somatic aspect, but also to the need for psychological management of these patients. It plays an extremely important role in palliative medicine and the treatment of cancer patients, as well as in neuropathic pain and neurological disease

Comparison of Retrolaminar Paravertebral Infiltration of a Non-Steroid Mixture with Conventional Epidural Steroid Infiltration in Patients Suffering from Chronic Radicular Pain- A Retrospective Study

AbstractIntroduction:Chronic radicular pain is often treated by epidural steroid infiltration (ESI). In 2014, Food and Drug Administration (FDA) issued a letter warning that ESI may result in rare but serious adverse events, including “loss of vision, stroke, paralysis, and death”. In this retrospective study, we compare retrolaminar paravertebral infiltration (PVI) of a non-steroid-mixture with ESI.Method:  We identified 31 patients registered in the Quebec Pain Registry suffering from chronic lumbar or cervical radicular pain referred to the Centre Hospitalier de l’Université de Montréal (CHUM) pain clinic between 2009 to 2014. These patients received ultrasound-guided retrolaminar PVI with a mixture of morphine 1 mg, ketamine 10 mg, neostigmine 0.5 mg, naloxone 2 ng, and bupivacaine 10 mg. The control group, matched for gender, age, and DN4 sub-scale score at baseline, consisted of 31 patients with the same pathology; they were treated by fluoroscopic-guided ESI. Principal pathologies in both groups were disc disorders and/or foraminal stenosis. All patients received only one infiltration during the six months following the initial visit. The numerical rating scale (NRS-11) was assessed at the first visit and six months later. The BPI, PCS and SF-12 were compared in both groups. Overall satisfaction in pain relief after six months was assessed with a scale of 1 (very unsatisfied) to 6 (very satisfied).Results: Average NRS-11 scores for the seven days preceding the first visit and after six months were compared in both groups. The same comparison was made for overal1 treatment satisfaction. There is no significant difference in the NRS-11 and in the satisfaction scores between the two groups.Discussion/conclusion: Neither of the two methods was shown to be superior to the other in pain relief and overall treatment satisfaction after six months. Considering the possible complications and side effects of ESI, PVI with a non-steroid mixture might be considered as an alternative method. Possibly, multiple PVIs could further decrease pain. Well-designed studies are needed to evaluate this hypothesis

The Neuroprotective Effects of mGlu1 Receptor Antagonists Are Mediated by an Enhancement of GABAergic Synaptic Transmission via a Presynaptic CB1 Receptor Mechanism

In this study, we investigated the cross-talk between mGlu1 and CB1 receptors in modulating GABA hippocampal output in whole-cell voltage clamp recordings in rat hippocampal acute slices, in organotypic hippocampal slices exposed to oxygen and glucose deprivation (OGD) and in gerbils subjected to global ischemia. CB1 receptor expression was studied using immunohistochemistry and the CA1 contents of anandamide (AEA) and 2-arachidonoylglycerol (2-AG) were measured by LC-MS/MS. Our results show that mGlu1 receptor antagonists enhance sIPSCs in CA1 pyramidal cells and the basal and ischemic hippocampal release of GABA in vivo in a manner that is mediated by CB1 receptor activation. In hippocampal slices exposed to OGD and in ischemic gerbils, mGlu1 receptor antagonists protected CA1 pyramidal cells against post-ischemic injury and this effect was reduced by CB1 receptor activation. OGD induced a transient increase in the hippocampal content of AEA and this effect is prevented by mGlu1 receptor antagonist. Finally, OGD induced a late disruption of CB1 receptors in the CA1 region and the effect was prevented when CA1 pyramidal cells were protected by mGlu1 antagonists. Altogether, these results suggest a cooperative interaction between mGlu1 receptors and the endocannabinoid system in the mechanisms that lead to post-ischemic neuronal death